Employer Direct Healthcare, announced its Product Steering Committee for CareCentral™, its new end-to-end oncology solution. The committee will be comprised of leaders from major Fortune 500 companies, public and education sector entities and other large private-sector employers across diverse industries including retail, food services, transportation, metals & mining, amongst others, including:
HR Technology News: Rubrik Appoints Lillian Reaume as Chief People Officer
- Matt Harmon – VP, Benefits, Compensation and HR Systems for AutoZone
- Mike Adams – former VP of Benefits and HR Systems for Dean Foods and current Senior Advisor to the Employer Health Innovation Roundtable
- Emily Ricci – Chief Health Administrator for the State of Alaska employee and retiree health plans
- Mark Weinstein – Chief Executive Officer of Independent Colleges and Universities Benefits Association, an organization representing 26 employers across Florida
- Pat Pitsch – Director Medical Benefits and Communication for BNSF Railway
- Rhonda Wright – Sr. Manager of Benefits and Leave for Academy Sports + Outdoors
Rapidly escalating costs, sensitive nature of treatment, and substantial variability in outcomes makes oncology a top focus area for employers. EDH is partnering with many of the nation’s top employers to proactively design a comprehensive solution to help members navigate patients’ oncological needs from diagnosis through treatment. The goal of the solution is to help members receive the best quality care under the latest protocols, in an accessible fashion through expert care coordination.
HR Technology News: Jeremy Haney Joins Old Mission as Head of Talent Management
Employer Direct Healthcare CEO, John Zutter, explained, “Anyone who has been impacted by the hardships of cancer, directly or indirectly, knows that it isn’t about a simple episode or surgical bundle; we need to support members throughout their complicated and individual journeys. Our objective is to help our members receive the best quality care in a localized fashion, wherever possible, with support from and access to the world’s leading cancer institutes. This mission requires access to expert opinions, care advocacy and specialty fulfillment. With the support of our clients, we look forward to improving patient pathways and outcomes in this important care category.”